The predictive validity of body mass index based on self-reported weight and height.

PubWeight™: 2.65‹?› | Rank: Top 1%

🔗 View Article (PMID 2793299)

Published in Int J Obes on January 01, 1989

Authors

A Kuskowska-Wolk1, P Karlsson, M Stolt, S Rössner

Author Affiliations

1: Obesity Unit, King Gustaf V Research Institute, Stockholm, Sweden.

Articles citing this

The validity of self-reported weight in US adults: a population based cross-sectional study. BMC Public Health (2001) 4.19

Some examples of regression towards the mean. BMJ (1994) 4.01

Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001-2006. BMC Public Health (2009) 3.68

Ethnic variation in validity of classification of overweight and obesity using self-reported weight and height in American women and men: the Third National Health and Nutrition Examination Survey. Nutr J (2005) 3.51

Accuracy of the estimated prevalence of obesity from self reported height and weight in an adult Scottish population. J Epidemiol Community Health (2000) 2.50

Accuracy of self-reported body weight, height and waist circumference in a Dutch overweight working population. BMC Med Res Methodol (2008) 1.91

Obesity and colorectal cancer risk in women. Gut (2002) 1.79

Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev (2008) 1.77

Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer (2005) 1.71

Obesity - a risk factor for postoperative complications in general surgery? BMC Anesthesiol (2015) 1.52

Obesity and renal cell cancer--a quantitative review. Br J Cancer (2001) 1.51

Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47

Weight loss advice U.S. obese adults receive from health care professionals. Prev Med (2008) 1.30

Validity of web-based self-reported weight and height: results of the Nutrinet-Santé study. J Med Internet Res (2013) 1.28

Risk factors for new episodes of sick leave due to neck or back pain in a working population. A prospective study with an 18-month and a three-year follow-up. Occup Environ Med (2006) 1.19

The weights and heights of Mexican-American adolescents: the accuracy of self-reports. Am J Public Health (1994) 1.15

GP documentation of obesity: what does it achieve? Br J Gen Pract (1998) 1.11

Disability among lesbian, gay, and bisexual adults: disparities in prevalence and risk. Am J Public Health (2011) 1.09

Adiposity and incidence of heart failure hospitalization and mortality: a population-based prospective study. Circ Heart Fail (2009) 1.07

Levelling off of prevalence of obesity in the adult population of Sweden between 2000/01 and 2004/05. BMC Public Health (2010) 1.06

Extent and determinants of discrepancy between self-evaluations of weight status and clinical standards. J Gen Intern Med (2001) 1.04

Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study. Br J Cancer (2011) 0.96

Self-reported versus measured height and weight in Hispanic and non-Hispanic menopausal women. J Womens Health (Larchmt) (2011) 0.94

Prevalence of obesity among children in six Chicago communities: findings from a health survey. Public Health Rep (2008) 0.92

Prevalence of overweight and obesity in Italy (2001-2008): is there a rising obesity epidemic? Ann Epidemiol (2010) 0.90

The association between excess weight and comorbidity and self-rated health in the Italian population. Ann Epidemiol (2013) 0.88

Longitudinal age-and cohort trends in body mass index in Sweden--a 24-year follow-up study. BMC Public Health (2013) 0.87

Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies. PLoS One (2015) 0.85

Validity of self-measured waist and hip circumferences: results from a community study in Malaysia. Nutr J (2013) 0.83

Risk factors for foot fracture among individuals aged 45 years and older. Osteoporos Int (2004) 0.83

Glycemic index and glycemic load in relation to body mass index and waist to hip ratio. Eur J Nutr (2010) 0.82

Comparisons of measured and self-reported anthropometric variables and blood pressure in a sample of Hong Kong female nurses. PLoS One (2014) 0.80

Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study. Fam Cancer (2007) 0.80

Overweight and obesity and related factors in urban Iranian population aged between 20 to 84 years. Ann Med Health Sci Res (2013) 0.79

Validation of self-reported height and weight in fifth-grade Korean children. Nutr Res Pract (2013) 0.79

Obesity prevalence in a cohort of women in early pregnancy from a neighbourhood perspective. BMC Pregnancy Childbirth (2009) 0.78

Dietary exposure to polychlorinated biphenyls and risk of breast, endometrial and ovarian cancer in a prospective cohort. Br J Cancer (2016) 0.75

Need for weight management in Switzerland: findings from National Blood Pressure Week 2009. BMC Public Health (2011) 0.75

Lifestyle and Risk of Screening-Detected Abdominal Aortic Aneurysm in Men. J Am Heart Assoc (2017) 0.75

Articles by these authors

(truncated to the top 100)

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06

Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev (2005) 5.72

Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet (2001) 3.60

Flaws in methods of evidence-based medicine may adversely affect public health directives. Surgery (2005) 3.49

Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study. Lancet (1978) 2.32

Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr (1997) 2.27

Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol (2000) 2.24

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond) (2011) 2.08

Open randomised trial of intermittent very low energy diet together with nicotine gum for stopping smoking in women who gained weight in previous attempts to quit. BMJ (1999) 2.04

Quality of alternative medicine--complications and avoidable deaths. Qual Assur Health Care (1990) 2.00

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry (1995) 1.80

Weight development over time in parous women--the SPAWN study--15 years follow-up. Int J Obes Relat Metab Disord (2003) 1.78

Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors. Diabetologia (1994) 1.73

Maternal body weight development after pregnancy. Int J Obes (1990) 1.72

Night eating and nocturnal eating-two different or similar syndromes among obese patients? Int J Obes Relat Metab Disord (2001) 1.63

Weight maintenance after a very low calorie diet (VLCD) weight reduction period and the effects of VLCD supplementation. A prospective, randomized, comparative, controlled long-term trial. J Intern Med (1995) 1.58

Long-term effects of a very low calorie diet (Nutrilett) in obesity treatment. A prospective, randomized, comparison between VLCD and a hypocaloric diet+behavior modification and their combination. Int J Obes Relat Metab Disord (1997) 1.58

Trends in eating patterns, physical activity and socio-demographic factors in relation to postpartum body weight development. Br J Nutr (1994) 1.54

Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev (2000) 1.53

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord (1999) 1.41

Acrylamide: a cooking carcinogen? Chem Res Toxicol (2000) 1.40

Obesity treatment and attrition: no relationship to obesity level. Obes Res (1996) 1.39

Preparation of a potential positron emission tomographic radioligand for the dopamine transporter. Eur J Nucl Med (1994) 1.38

Long-term weight development after pregnancy. Obes Rev (2002) 1.35

Cancer incidence after radiotherapy for skin haemangioma during infancy. Acta Oncol (1995) 1.33

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr (1998) 1.32

Prevalence of obesity in Sweden. Obes Rev (2006) 1.28

An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Hum Reprod (1997) 1.28

Is walking for exercise too exhausting for obese women? Int J Obes Relat Metab Disord (1997) 1.23

Factors related to body weight changes during and after pregnancy: the Stockholm Pregnancy and Weight Development Study. Obes Res (1996) 1.21

Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur J Immunol (2000) 1.21

Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines. Int J Obes Relat Metab Disord (2003) 1.20

Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. J Nucl Med (1995) 1.18

Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants. Radiat Res (1999) 1.17

The Christmas factor in obesity therapy. Int J Obes Relat Metab Disord (1992) 1.16

Eating behaviour in obese and normal weight 11-year-old children. Int J Obes Relat Metab Disord (1992) 1.15

Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes. Diabetes Obes Metab (2007) 1.14

Normal serum-cholesterol but low H.D.L.-cholesterol concentration in young patients with ischaemic cerebrovascular disease. Lancet (1978) 1.12

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12

Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol (1996) 1.11

A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Cancer Res (1998) 1.11

Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. Obes Rev (2009) 1.10

Social mapping of the obesity epidemic in Sweden. Int J Obes Relat Metab Disord (2000) 1.08

Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis. Oncogene (2011) 1.07

Disability pension, employment and obesity status: a systematic review. Obes Rev (2008) 1.05

An Internet-based weight loss programme -- a feasibility study with preliminary results from 4209 completers. Scand J Public Health (2008) 1.05

Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis (1984) 1.03

Increased physical activity in abdominally obese women through support for changed commuting habits: a randomized clinical trial. Int J Obes (Lond) (2009) 1.02

Outcome of reproduction in women irradiated for skin hemangioma in infancy. Radiat Res (1998) 1.02

Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid. Atherosclerosis (1974) 1.01

Sexual function in obese women: impact of lower urinary tract dysfunction. Int J Obes (Lond) (2008) 1.01

Randomized, multi-center trial of two hypo-energetic diets in obese subjects: high- versus low-fat content. Int J Obes (Lond) (2006) 1.01

Long term treatment of severe obesity: four year follow up of results of combined behavioural modification programme. Br Med J (Clin Res Ed) (1985) 1.00

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Ann Oncol (2011) 1.00

Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success. Diabetes Obes Metab (2007) 0.99

Effects of a high-protein meal (meat) and a high-carbohydrate meal (vegetarian) on satiety measured by automated computerized monitoring of subsequent food intake, motivation to eat and food preferences. Int J Obes (1990) 0.99

Discrepancies between classification systems of childhood obesity. Obes Rev (2004) 0.98

Serum lipoprotein changes during atenolol treatment of essential hypertension. Eur J Clin Pharmacol (1981) 0.98

Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance. Int J Obes Relat Metab Disord (2001) 0.98

Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups. J Pediatr (2000) 0.97

A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology (Berl) (1997) 0.97

[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo. Eur J Nucl Med (1998) 0.97

Beta-blockers and running. Am Heart J (1980) 0.96

Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int (1998) 0.96

Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial. Diabetes Obes Metab (2005) 0.95

Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia (2000) 0.95

Prevalence of obesity in Sweden: cross-sectional study of a representative adult population. J Intern Med (1990) 0.94

Early and late effects of weight loss on lipoprotein metabolism in severe obesity. Atherosclerosis (1987) 0.94

Mobile computerized tomography scanning in the neurosurgery intensive care unit: increase in patient safety and reduction of staff workload. J Neurosurg (2000) 0.94

Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis. Obes Rev (2010) 0.92

Melatonin secretion related to side-effects of beta-blockers from the central nervous system. Acta Med Scand (1988) 0.92

Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans. Gut (2003) 0.91

Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans. Int J Obes (Lond) (2009) 0.91

A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer. Eur J Cancer (2001) 0.91

Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study. Neuroscience (2010) 0.91

The "true" prevalence of obesity. A comparison of objective weight and height measures versus self-reported and calibrated data. Scand J Prim Health Care (1989) 0.91

Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. J Nucl Med (1998) 0.90

Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease. Eur Arch Psychiatry Clin Neurosci (1994) 0.90

Medical education in the Nordic countries. Nord Med (1974) 0.90

Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activity. Acta Med Scand (1971) 0.90

The criterion validity of a last 7-day physical activity questionnaire (SAPAQ) for use in adolescents with a wide variation in body fat: the Stockholm Weight Development Study. Int J Obes (Lond) (2006) 0.89

Intake of sweet foods and counts of cariogenic microorganisms in relation to body mass index and psychometric variables in women. Int J Obes Relat Metab Disord (2002) 0.89

Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy. Br J Cancer (2001) 0.89

Agglutinate formation in serum samples mixed with intravenous fat emulsions. Crit Care Med (1985) 0.88

Meal patterns in obese and normal weight men: the 'Gustaf' study. Eur J Clin Nutr (1996) 0.87

Personality traits predicting weight loss outcome in obese patients. Acta Psychiatr Scand (1986) 0.87

Eating habits in relation to body fatness and gender in adolescents--results from the 'SWEDES' study. Eur J Clin Nutr (2006) 0.87

PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain. Synapse (1994) 0.87

Dyslipoproteinaemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test). Atherosclerosis (1977) 0.86

A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain. Psychopharmacology (Berl) (1999) 0.86

Utilization of radioligands in schizophrenia research. Clin Neurosci (1995) 0.86

Long-term physical training in female type 1 (insulin-dependent) diabetic patients: absence of significant effect on glycaemic control and lipoprotein levels. Diabetologia (1986) 0.86

Changes in high density lipoprotein subfractions and other lipoproteins by exercise. Clin Chim Acta (1981) 0.86

A ten-year follow-up of weight change in severely obese subjects treated in a combined behavioural modification programme. Int J Obes Relat Metab Disord (1992) 0.86

Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study. Br J Cancer (2013) 0.85

Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity. Clin Sci (Lond) (1995) 0.85

Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome. Int J Obes Relat Metab Disord (2003) 0.85

Effects of cycloheximide, brefeldin A, suramin, heparin and primaquine on proteoglycan and glycosaminoglycan biosynthesis in human embryonic skin fibroblasts. Biochim Biophys Acta (1992) 0.85

Effects of milk or water on lunch intake in preschool children. Appetite (1998) 0.84

Body weight characteristics of subjects on asthma medication. Int J Obes Relat Metab Disord (2000) 0.84